StemCells Inc Profile





10 Days Price Trend
October 13, 2015Advice  Valuation
Highest PriceSeptember 9, 20150.59
Lowest PricOctober 8, 20150.4

StemCells Inc Market Sensitivity

As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, StemCells Inc will likely underperform.

StemCells Inc Market Cap Over Time

NameStemCells Inc
InstrumentUSA Stock
Contact Number510 456 4000
Analyst ConsensusStrong Buy 4 Opinions
Risk-adjusted AdviceStrong Sell Under Valued
CurrencyUSD - US Dollar
ExchangeNasdaq Capital Markets
DescriptionStemCells Inc. a biopharmaceutical company researches develops and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more

Key Fundamentals

StemCells Inc Agains Markets

 United States Nasdaq   0.17 % Macroaxis: 0.17 Moved Up  
 United States SP 500   0.13 % Macroaxis: 0.13 Moved Up  
 United States NYSE   0.05 % Macroaxis: 0.0461 Moved Down  
 United States Russel   0.08 % Macroaxis: 0.081589 Moved Down  
 thisRed STEM STEM agains markets  3.98 % Macroaxis: change 3.9836 Moved Down  
Compare to Competition   Compare Correlations

StemCells Inc Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Inc Diversification Suggestion

Use StemCells Inc to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of StemCells Inc to be traded at $0.4049 in 30 days

StemCells Inc Daily Price Distribution

The median price of StemCells Inc for the period between Sun, Sep 13, 2015 and Tue, Oct 13, 2015 is 0.47 with a coefficient of variation of 12.12. The daily time series for the period is distributed with a sample standard deviation of 0.06, arithmetic mean of 0.48, and mean deviation of 0.05. The Stock received some media coverage during the period.

StemCells Inc Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 54.8 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 108.52 M outstanding shares of which 1.8 M shares are at this time shorted by private and institutional investors with about 4.05 trading days to cover.

StemCells Inc Accumulated Other Comprehensive Income Over Time

StemCells Inc Alerts

StemCells Inc generates negative expected return over the last 30 days
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high historical volatility and very poor performance
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 1.02 M. Net Loss for the year was (30.54 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 29.93 M in cash with (29.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Company Shares of StemCells Inc. Drops by 0.16

StemCells Inc Upcoming Events

Upcoming Quarterly ReportNovember 4, 2015
Next Earnings ReportMarch 21, 2016

StemCells Inc Earnings Estimates

EPSEstimate Date
Quarterly Estimate-0.1November 4, 2015
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Inc Earnings Estimate  

StemCells Inc Analyst Recommendations

Target PriceConsensus AdviceNumber of Analysts
2.387Strong Buy4
StemCells Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
StemCells Inc Analyst Recommendations  

StemCells Inc Research Report

Get StemCells Inc research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells Inc report to view

StemCells Inc Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells Inc and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing idea could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Inc Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Megan Meloni Director of Investor Relations and Corporate Communications

StemCells Inc Fundamentals Correlation

StemCells Inc vs Competition

StemCells Inc October 13, 2015 Opportunity Range